DAPA MET 5MG+850MG 28s

DAPA MET Tablets combine Dapagliflozin (5mg) and Metformin (850mg) — two powerful anti-diabetic agents used together to control blood sugar levels in adults with Type 2 Diabetes Mellitus (T2DM). This dual-action formula helps the body use insulin more effectively and eliminates excess sugar through urine, offering improved glycemic control and weight management.

Uses:

• Management of Type 2 Diabetes Mellitus

• Helps lower high blood glucose levels

• Reduces the risk of diabetic complications such as kidney damage, neuropathy, and heart disease

• Supports weight loss and improves insulin sensitivity

• Can be used as part of combination therapy with other anti-diabetic medicines

Benefits:

• Dual mechanism of action: Dapagliflozin removes excess glucose via urine, while Metformin decreases sugar production in the liver

• Improves blood sugar control: Reduces fasting and post-meal glucose levels

• Supports heart and kidney health: Provides cardiovascular and renal protection in diabetic patients

• Aids in weight management: Promotes mild weight reduction and better metabolic control

• Enhances insulin response: Helps the body use insulin more efficiently

Possible Side Effects:

• Nausea, diarrhea, or stomach upset (usually mild and temporary)

• Frequent urination or mild dehydration

• Low blood sugar (especially when used with other diabetes medicines)

• Rarely, urinary tract or genital infections due to excess glucose in urine

• Metallic taste or mild fatigue